Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29

1.

The outcome spectrum of multiple sclerosis: disability, mortality, and a cluster of predictors from onset.

Tedeholm H, Skoog B, Lisovskaja V, Runmarker B, Nerman O, Andersen O.

J Neurol. 2015 Feb 26. [Epub ahead of print]

PMID:
25712541
2.

A Sleep Apnea-Related Risk of Motor Vehicle Accidents is Reduced by Continuous Positive Airway Pressure: Swedish Traffic Accident Registry Data.

Karimi M, Hedner J, Häbel H, Nerman O, Grote L.

Sleep. 2015 Mar 1;38(3):341-9. doi: 10.5665/sleep.4486.

PMID:
25325460
3.

The association between HbA1c, fasting glucose, 1-hour glucose and 2-hour glucose during an oral glucose tolerance test and cardiovascular disease in individuals with elevated risk for diabetes.

Lind M, Tuomilehto J, Uusitupa M, Nerman O, Eriksson J, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Peltonen M, Pivodic A, Lindström J.

PLoS One. 2014 Oct 6;9(10):e109506. doi: 10.1371/journal.pone.0109506. eCollection 2014.

4.

Changes in HbA1c and frequency of measuring HbA1c and adjusting glucose-lowering medications in the 10 years following diagnosis of type 2 diabetes: a population-based study in the UK.

Lind M, Pivodic A, Cea-Soriano L, Nerman O, Pehrsson NG, Garcia-Rodriguez LA.

Diabetologia. 2014 Aug;57(8):1586-94. doi: 10.1007/s00125-014-3250-8. Epub 2014 May 9.

PMID:
24811709
5.

A novel method for cross-species gene expression analysis.

Kristiansson E, Österlund T, Gunnarsson L, Arne G, Larsson DG, Nerman O.

BMC Bioinformatics. 2013 Feb 27;14:70. doi: 10.1186/1471-2105-14-70.

6.

Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs.

Tedeholm H, Lycke J, Skoog B, Lisovskaja V, Hillert J, Dahle C, Fagius J, Fredrikson S, Landtblom AM, Malmeström C, Martin C, Piehl F, Runmarker B, Stawiarz L, Vrethem M, Nerman O, Andersen O.

Mult Scler. 2013 May;19(6):765-74. doi: 10.1177/1352458512463764. Epub 2012 Nov 1.

7.

Transcriptional and metabolic data integration and modeling for identification of active pathways.

Jauhiainen A, Nerman O, Michailidis G, Jörnsten R.

Biostatistics. 2012 Sep;13(4):748-61. doi: 10.1093/biostatistics/kxs016. Epub 2012 Jun 14.

8.

Distinct cytoplasmic and nuclear functions of the stress induced protein DDIT3/CHOP/GADD153.

Jauhiainen A, Thomsen C, Strömbom L, Grundevik P, Andersson C, Danielsson A, Andersson MK, Nerman O, Rörkvist L, Ståhlberg A, Åman P.

PLoS One. 2012;7(4):e33208. doi: 10.1371/journal.pone.0033208. Epub 2012 Apr 9.

9.

Expression profiling of GIST: CD133 is associated with KIT exon 11 mutations, gastric location and poor prognosis.

Arne G, Kristiansson E, Nerman O, Kindblom LG, Ahlman H, Nilsson B, Nilsson O.

Int J Cancer. 2011 Sep 1;129(5):1149-61. doi: 10.1002/ijc.25755. Epub 2011 Jan 7.

PMID:
21064103
10.

Testing of chromosomal clumping of gene properties.

Fernandez-Ricaud L, Dalevi D, Blomberg A, Nerman O.

Stat Appl Genet Mol Biol. 2009;8:Article 19. doi: 10.2202/1544-6115.1428. Epub 2009 Feb 26.

PMID:
19341353
11.

Genetic basis of arsenite and cadmium tolerance in Saccharomyces cerevisiae.

Thorsen M, Perrone GG, Kristiansson E, Traini M, Ye T, Dawes IW, Nerman O, Tamás MJ.

BMC Genomics. 2009 Mar 12;10:105. doi: 10.1186/1471-2164-10-105.

12.

Evolutionary forces act on promoter length: identification of enriched cis-regulatory elements.

Kristiansson E, Thorsen M, Tamás MJ, Nerman O.

Mol Biol Evol. 2009 Jun;26(6):1299-307. doi: 10.1093/molbev/msp040. Epub 2009 Mar 3.

13.

mRNA stability changes precede changes in steady-state mRNA amounts during hyperosmotic stress.

Molin C, Jauhiainen A, Warringer J, Nerman O, Sunnerhagen P.

RNA. 2009 Apr;15(4):600-14. doi: 10.1261/rna.1403509. Epub 2009 Feb 17.

14.

Evolutionary conservation of human drug targets in organisms used for environmental risk assessments.

Gunnarsson L, Jauhiainen A, Kristiansson E, Nerman O, Larsson DG.

Environ Sci Technol. 2008 Aug 1;42(15):5807-13.

PMID:
18754513
15.

[Systems biology can radically change health care. Basis for individualized prediction, prevention and treatment].

Benson M, Cardell LO, Hohmann S, Jirstrand M, Langston M, Mobini R, Nerman O.

Lakartidningen. 2007 Oct 17-23;104(42):3037-41. Review. Swedish. No abstract available.

PMID:
17985710
16.

Weighted analysis of general microarray experiments.

Sjögren A, Kristiansson E, Rudemo M, Nerman O.

BMC Bioinformatics. 2007 Oct 15;8:387.

17.

Sensitive and robust gene expression changes in fish exposed to estrogen--a microarray approach.

Gunnarsson L, Kristiansson E, Förlin L, Nerman O, Larsson DG.

BMC Genomics. 2007 Jun 7;8:149.

18.

Quantitative transcriptome, proteome, and sulfur metabolite profiling of the Saccharomyces cerevisiae response to arsenite.

Thorsen M, Lagniel G, Kristiansson E, Junot C, Nerman O, Labarre J, Tamás MJ.

Physiol Genomics. 2007 Jun 19;30(1):35-43. Epub 2007 Feb 27.

19.

PROPHECY--a yeast phenome database, update 2006.

Fernandez-Ricaud L, Warringer J, Ericson E, Glaab K, Davidsson P, Nilsson F, Kemp GJ, Nerman O, Blomberg A.

Nucleic Acids Res. 2007 Jan;35(Database issue):D463-7. Epub 2006 Dec 5.

20.

Quality optimised analysis of general paired microarray experiments.

Kristiansson E, Sjögren A, Rudemo M, Nerman O.

Stat Appl Genet Mol Biol. 2006;5:Article10. Epub 2006 Apr 21.

PMID:
16646864
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk